TherapeuticsMD, Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TherapeuticsMD, Inc. stock issued during period, value, other for the quarter ending 2023-06-30 was $1.15M.
- TherapeuticsMD, Inc. stock issued during period, value, other for the quarter ending 2019-03-31 was $100.11K.
- TherapeuticsMD, Inc. stock issued during period, value, other for the quarter ending 2015-03-31 was $925.49K.
- TherapeuticsMD, Inc. stock issued during period, value, other for the quarter ending 2014-12-31 was $0.00.
- TherapeuticsMD, Inc. stock issued during period, value, other for fiscal 2023 was $3.15M.
- TherapeuticsMD, Inc. stock issued during period, value, other for fiscal 2017 was $3.80M, a 284.10% increase from fiscal 2016.
- TherapeuticsMD, Inc. stock issued during period, value, other for fiscal 2016 was $989.06K, a 170.23% increase from fiscal 2015.
- TherapeuticsMD, Inc. stock issued during period, value, other for fiscal 2015 was $366.00K, a 102.21% increase from fiscal 2014.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2023-12-31 | $3.15M 10-K · filed 2024-03-29 | |
| 2023-06-30 | $1.15M 10-Q · filed 2024-08-12 | |
| 2019-03-31 | $100.11K 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $3.80M 10-K · filed 2020-02-24 | |
| 2016-12-31 | $989.06K 10-K · filed 2019-02-27 | |
| 2015-12-31 | $366.00K 10-K · filed 2018-02-23 | |
| 2015-03-31 | $925.49K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $181.00K 10-K · filed 2017-02-28 |
| 2014-09-30 | $94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | |
| 2012-12-31 | $3.10M 10-K · filed 2015-03-12 | |
| 2011-12-31 | $17.25K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |